These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 15125792

  • 1. Maintenance of increased bone mass after recombinant human parathyroid hormone (1-84) with sequential zoledronate treatment in ovariectomized rats.
    Rhee Y, Won YY, Baek MH, Lim SK.
    J Bone Miner Res; 2004 Jun; 19(6):931-7. PubMed ID: 15125792
    [Abstract] [Full Text] [Related]

  • 2. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
    Shen V, Birchman R, Wu DD, Lindsay R.
    J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
    [Abstract] [Full Text] [Related]

  • 3. Both hPTH(1-34) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture.
    Lane NE, Yao W, Kinney JH, Modin G, Balooch M, Wronski TJ.
    J Bone Miner Res; 2003 Dec; 18(12):2105-15. PubMed ID: 14672345
    [Abstract] [Full Text] [Related]

  • 4. Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats.
    Wronski TJ, Ratkus AM, Thomsen JS, Vulcan Q, Mosekilde L.
    J Bone Miner Res; 2001 Aug; 16(8):1399-407. PubMed ID: 11499862
    [Abstract] [Full Text] [Related]

  • 5. Maintaining bone mass by bisphosphonate incadronate disodium (YM175) sequential treatment after discontinuation of intermittent human parathyroid hormone (1-34) administration in ovariectomized rats.
    Takano Y, Tanizawa T, Mashiba T, Endo N, Nishida S, Takahashi HE.
    J Bone Miner Res; 1996 Feb; 11(2):169-77. PubMed ID: 8822340
    [Abstract] [Full Text] [Related]

  • 6. Accretion of bone mass and strength with parathyroid hormone prior to the onset of estrogen deficiency can provide temporary beneficial effects in skeletally mature rats.
    Shen V, Birchman R, Liang XG, Wu DD, Dempster DW, Lindsay R.
    J Bone Miner Res; 1998 May; 13(5):883-90. PubMed ID: 9610753
    [Abstract] [Full Text] [Related]

  • 7. Partial maintenance of extra cancellous bone mass by antiresorptive agents after discontinuation of human parathyroid hormone (1-38) in right hindlimb immobilized rats.
    Ma Y, Jee WS, Chen Y, Gasser J, Ke HZ, Li XJ, Kimmel DB.
    J Bone Miner Res; 1995 Nov; 10(11):1726-34. PubMed ID: 8592950
    [Abstract] [Full Text] [Related]

  • 8. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J, Miller MA, Newman MK, Metcalfe AF, Turner CH, Recker RR, Smith SY.
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [Abstract] [Full Text] [Related]

  • 9. The addition of a raloxifene analog (LY117018) allows for reduced PTH(1-34) dosing during reversal of osteopenia in ovariectomized rats.
    Hodsman AB, Drost D, Fraher LJ, Holdsworth D, Thornton M, Hock J, Bryant H, Watson PH.
    J Bone Miner Res; 1999 May; 14(5):675-9. PubMed ID: 10320515
    [Abstract] [Full Text] [Related]

  • 10. [Effects of teriparatide and alendronate on bone mineral density of osteoporotic rats].
    Li M, Jiao J, Meng XW, Xing XP, Xia WB, Zhou XY, Liu HC, Jiang Y, Wang O, Hu YY, Zhan ZW.
    Zhonghua Yi Xue Za Zhi; 2005 Feb 02; 85(5):335-8. PubMed ID: 15854512
    [Abstract] [Full Text] [Related]

  • 11. Effects of recombinant human growth hormone and insulin-like growth factor-I, with or without 17 beta-estradiol, on bone and mineral homeostasis of aged ovariectomized rats.
    Verhaeghe J, van Bree R, Van Herck E, Thomas H, Skottner A, Dequeker J, Mosekilde L, Einhorn TA, Bouillon R.
    J Bone Miner Res; 1996 Nov 02; 11(11):1723-35. PubMed ID: 8915780
    [Abstract] [Full Text] [Related]

  • 12. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
    Tanaka M, Mori H, Kayasuga R, Ochi Y, Kawada N, Yamada H, Kishikawa K.
    Bone; 2008 Nov 02; 43(5):894-900. PubMed ID: 18687415
    [Abstract] [Full Text] [Related]

  • 13. Bone-selective analogs of human PTH(1-34) increase bone formation in an ovariectomized rat model.
    Lane NE, Kimmel DB, Nilsson MH, Cohen FE, Newton S, Nissenson RA, Strewler GJ.
    J Bone Miner Res; 1996 May 02; 11(5):614-25. PubMed ID: 9157776
    [Abstract] [Full Text] [Related]

  • 14. Treatment of skeletally mature ovariectomized rhesus monkeys with PTH(1-84) for 16 months increases bone formation and density and improves trabecular architecture and biomechanical properties at the lumbar spine.
    Fox J, Miller MA, Newman MK, Turner CH, Recker RR, Smith SY.
    J Bone Miner Res; 2007 Feb 02; 22(2):260-73. PubMed ID: 17087625
    [Abstract] [Full Text] [Related]

  • 15. Effect of combined humanPTH(1-34) and calcitonin treatment in ovariectomized rats.
    Washimi Y, Ito M, Morishima Y, Taguma K, Ojima Y, Uzawa T, Hori M.
    Bone; 2007 Nov 02; 41(5):786-93. PubMed ID: 17707708
    [Abstract] [Full Text] [Related]

  • 16. Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat.
    Zhou H, Shen V, Dempster DW, Lindsay R.
    J Bone Miner Res; 2001 Jul 02; 16(7):1300-7. PubMed ID: 11450706
    [Abstract] [Full Text] [Related]

  • 17. Cyclical treatment of osteopenic ovariectomized adult rats with PTH(1-34) and pamidronate.
    Cheng PT, Chan C, Müller K.
    J Bone Miner Res; 1995 Jan 02; 10(1):119-26. PubMed ID: 7747618
    [Abstract] [Full Text] [Related]

  • 18. Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893.
    Stewart AF, Cain RL, Burr DB, Jacob D, Turner CH, Hock JM.
    J Bone Miner Res; 2000 Aug 02; 15(8):1517-25. PubMed ID: 10934650
    [Abstract] [Full Text] [Related]

  • 19. Anabolic effects of recombinant human parathyroid hormone (1 - 84) and synthetic human parathyroid hormone (1 - 34) on the mandibles of osteopenic ovariectomized rats with maxillary molar extraction.
    Kawane T, Takahashi S, Saitoh H, Okamoto H, Kubodera N, Horiuchi N.
    Horm Metab Res; 2002 Jun 02; 34(6):293-302. PubMed ID: 12173069
    [Abstract] [Full Text] [Related]

  • 20. Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat.
    Gasser JA, Ingold P, Venturiere A, Shen V, Green JR.
    J Bone Miner Res; 2008 Apr 02; 23(4):544-51. PubMed ID: 18072878
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.